Axiom Investors LLC Veracyte, Inc. Transaction History

Axiom Investors LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$32.94 - $56.62 $1.37 Million - $2.35 Million	-41,465 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$44.47 - $81.38 $356,427 - $652,260	-8,015 Reduced 16.2%	41,465 $2.23 Million
Q4 2020 Feb 12, 2021	BUY	$32.49 - $61.88 $1.61 Million - $3.06 Million	49,480 New	49,480 $2.42 Million
Q4 2017 Feb 14, 2018	SELL	$6.05 - $9.37 $2.35 Million - $3.64 Million	-388,328 Closed	0 $0
Q3 2017 Nov 09, 2017	BUY	$7.81 - $8.77 $1.1 Million - $1.23 Million	140,783 Added 56.87%	388,328 $3.41 Million
Q2 2017 Aug 14, 2017	BUY	N/A	247,545	247,545 $2.06 Million

307

81.7M

134K

13.3K

Ticker VCYT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,575,904
Market Cap $2.57B
Description
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...

Get notified when there are updates to the investment portfolio of Axiom Investors LLC , based on Form 13F filings with the SEC.

Stay updated on Axiom Investors LLC with notifications on news.